Skip to main content
. Author manuscript; available in PMC: 2013 Sep 5.
Published in final edited form as: Am Heart J. 2012 Mar 27;163(5):804–811. doi: 10.1016/j.ahj.2012.02.008

Table 4. Rates for warfarin use at discharge in patients with heart failure and atrial fibrillation.

Country Unadjusted
Rate (%)
Risk-Adjusted
Rate* (%)
OR
(95% CI)
P Value
Mexico 60.0 48.6 2.34 (1.2–4.59) 0.0132
Australia 59.4 65.2 3.74 (2.24–6.27) <0.0001
Hong Kong 43.0 52.5 1.99 (1.28–3.10) <0.0021
Indonesia 36.2 34.3 0.88 (0.37–2.06) 0.76
Malaysia 50.8 52.9 2.08 (1.31–3.30) 0.0018
Philippines 30.3 25.5 0.52 (0.33–0.84) <0.0076
Singapore 30.2 35.8 1.01 (0.64–1.59) 0.96
Taiwan 18.3 25.1 0.62 (0.36–1.04) 0.0721
Thailand 49.4 49.4 1.93 (1.18–3.15) 0.0086
Brazil 34.4 37.5 Reference --
*

Adjusted for age, coronary artery disease, pacemaker, and creatinine levels.

CI indicates confidence interval; OR, odds ratio.